Skip to main content

Table 5 Vital signs (means ± standard deviation) in the ITT population.

From: Safety and effects of two mistletoe preparations on production of Interleukin-6 and other immune parameters - a placebo controlled clinical trial in healthy subjects

 

Group

Baseline

Exposure

Exposure

Exposure

Follow-up

   

Week 4

Week 8

Week 12

Week 16

Body temperature

IP

36.4 ± 0.4

36.4 ± 0.4

36.3 ± 0.5

36.4 ± 0.4

36.5 ± 0.3

 

VM

36.5 ± 0.4

36.2 ± 0.5

36.3 ± 0.5

36.3 ± 0.3

36.4 ± 0.3

 

PL

36.3 ± 0.4

36.3 ± 0.3

36.4 ± 0.4

36.4 ± 0.3

36.5 ± 0.4

Systolic blood pressure

IP

120 ± 11

117 ± 11

114 ± 10

117 ± 11

112 ± 12

 

VM

112 ± 10

114 ± 10

110 ± 11

111 ± 12

112 ± 13

 

PL

112 ± 13

110 ± 11

113 ± 9

111 ± 13

112 ± 13

Heart rate

IP

76 ± 11

72 ± 7

74 ± 9

71 ± 9

72 ± 11

 

VM

71 ± 9

74 ± 11

70 ± 8

68 ± 8

66 ± 9

 

PL

74 ± 8

71 ± 9

72 ± 6

72 ± 9

74 ± 7

  1. IP = Iscucin® Populi, VM = Viscum Mali e planta tota, PL = placebo.